Sex Differences in Cortical Thickness and Neuropsychiatric Symptom Burden Based on APOE4 Homozygosity in Alzheimer's Disease

被引:1
|
作者
Khoury, Marc A. [1 ,2 ]
Valcic, Mila [1 ]
Churchill, Nathan W. [1 ]
Di Battista, Alex [3 ]
De Luca, Vincenzo [4 ]
Fornazzari, Luis R. [1 ,5 ]
Munoz, David G. [1 ,2 ,6 ]
Fischer, Corinne E. [1 ,2 ,7 ]
Schweizer, Tom A. [1 ,2 ,8 ]
机构
[1] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada
[2] Univ Toronto, Inst Med Sci, Temerty Fac Med, Toronto, ON, Canada
[3] Def Res & Dev Canada, Toronto Res Ctr, Toronto, ON, Canada
[4] Ctr Addict & Mental Hlth, Div Geriatr Psychiat, Toronto, ON, Canada
[5] Univ Toronto, Dept Med, Neurol Div, Toronto, ON, Canada
[6] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[7] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON, Canada
[8] Univ Toronto, Fac Med, Div Neurosurg, Toronto, ON, Canada
关键词
Alzheimer's disease; APOE4; cortical thickness; neuropsychiatric symptoms; sex differences; APOLIPOPROTEIN-E; BRAIN STRUCTURE; ASSOCIATION; EPSILON-4; GENDER; RISK; AGE; GENOTYPE; DECLINE; ALLELE;
D O I
10.1002/ajmg.b.33008
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Sex differences in patterns of cortical thickness and neuropsychiatric symptom (NPS) burden were examined among individuals with Alzheimer's disease (AD) and two copies (homozygote carriers) of the e4 allele of the apolipoprotein gene (APOE). A total of 752 participants with a clinical etiologic diagnosis of AD were selected from the National Alzheimer's Coordinating Center (NACC) database. Bayesian multilevel regression was used to examine both the within- and between-sex differences in gray-matter cortical thickness and total NPS burden associated with APOE homozygosity. Female homozygote carriers displayed a high probability of having reduced cortical thickness primarily in medial-lateral temporal regions and a greater burden of NPS, relative to both non-homozygous females and homozygous males. These findings support the notion that APOE4 status affects cortical thickness and symptom burden in men and women with AD differentially, with females showing more pronounced effects in brain areas known to be vulnerable in early AD. Future investigations should attempt to elucidate the proposed pattern of decline longitudinally.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study
    Mattsson, Niklas
    Ossenkoppele, Rik
    Smith, Ruben
    Strandberg, Olof
    Ohlsson, Tomas
    Jogi, Jonas
    Palmqvist, Sebastian
    Stomrud, Erik
    Hansson, Oskar
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [42] APOEε4 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer's disease
    Polsinelli, Angelina J.
    Logan, Paige E.
    Lane, Kathleen A.
    Manchella, Mohit K.
    Nemes, Sara
    Sanjay, Apoorva Bharthur
    Gao, Sujuan
    Apostolova, Liana G.
    ALZHEIMERS & DEMENTIA, 2023, 19 (05) : 1983 - 1993
  • [43] ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease
    Li, Yonghe
    Macyczko, Jesse R.
    Liu, Chia-Chen
    Bu, Guojun
    NEUROBIOLOGY OF AGING, 2022, 115 : 20 - 28
  • [44] Effect of APOE4 Allele and Gender on the Rate of Atrophy in the Hippocampus, Entorhinal Cortex, and Fusiform Gyrus in Alzheimer's Disease
    Hamza, Eid Abo
    Moustafa, Ahmed A.
    Tindle, Richard
    Karki, Rasu
    Nalla, Shahed
    Hamid, Mohamed S.
    EL Haj, Mohamad
    CURRENT ALZHEIMER RESEARCH, 2022, 19 (14) : 943 - 953
  • [45] APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
    Md. Sahab Uddin
    Md. Tanvir Kabir
    Abdullah Al Mamun
    Mohamed M. Abdel-Daim
    George E. Barreto
    Ghulam Md Ashraf
    Molecular Neurobiology, 2019, 56 : 2450 - 2465
  • [46] APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis
    Uddin, Md. Sahab
    Kabir, Md. Tanvir
    Al Mamun, Abdullah
    Abdel-Daim, Mohamed M.
    Barreto, George E.
    Ashraf, Ghulam Md
    MOLECULAR NEUROBIOLOGY, 2019, 56 (04) : 2450 - 2465
  • [47] Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease
    Martiskainen, Henna
    Haapasalo, Annakaisa
    Kurkinen, Kaisa M. A.
    Pihlajamaki, Jussi
    Soininen, Hilkka
    Hiltunen, Mikko
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (07) : 781 - 794
  • [48] ApoE4 May be a Promising Target for Treatment of Coronary Heart Disease and Alzheimer's Disease
    Chen, Wei
    Jin, Fengzhong
    Cao, Guihua
    Mei, Rong
    Wang, Yayun
    Long, Pan
    Wang, Xiaoming
    Ge, Wei
    CURRENT DRUG TARGETS, 2018, 19 (09) : 1038 - 1044
  • [49] Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation
    Valencia-Olvera, Ana C.
    Balu, Deebika
    Faulk, Naomi
    Amiridis, Aspasia
    Wang, Yueting
    Pham, Christine
    Avila-Munoz, Eva
    York, Jason M.
    Thatcher, Gregory R. J.
    LaDu, Mary Jo
    NEUROTHERAPEUTICS, 2023, 20 (04) : 1120 - 1137
  • [50] Neuronal ApoE4 in Alzheimer's disease and potential therapeutic targets
    Zhang, Lan
    Xia, Yiyuan
    Gui, Yuran
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15